Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Amortization - Intangibles (2024 - 2025)

Journey Medical (DERM) has disclosed Amortization - Intangibles for 2 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortization - Intangibles rose 30.71% year-over-year to $1.1 million, compared with a TTM value of $4.2 million through Sep 2025, changed N/A, and an annual FY2024 reading of $3.4 million, down 9.11% over the prior year.
  • Amortization - Intangibles was $1.1 million for Q3 2025 at Journey Medical, roughly flat from $1.1 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $1.1 million in Q1 2025 and bottomed at $814000.0 in Q1 2024.